CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 209077-209302 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T93506","span":{"begin":0,"end":225},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Therefore, we are developing an animal model of these disorders by passive transfer of EL patient IgGs or active immunization with group A streptococcus homogenate, human basal ganglia and recombinant proteins (autoantigens)."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T54","span":{"begin":0,"end":225},"obj":"Sentence"}],"text":"Therefore, we are developing an animal model of these disorders by passive transfer of EL patient IgGs or active immunization with group A streptococcus homogenate, human basal ganglia and recombinant proteins (autoantigens)."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T51188","span":{"begin":87,"end":89},"obj":"Disease"},{"id":"T75611","span":{"begin":87,"end":89},"obj":"Disease"}],"attributes":[{"id":"A74872","pred":"mondo_id","subj":"T51188","obj":"http://purl.obolibrary.org/obo/MONDO_0019384"},{"id":"A86968","pred":"mondo_id","subj":"T75611","obj":"http://purl.obolibrary.org/obo/MONDO_0019384"}],"text":"Therefore, we are developing an animal model of these disorders by passive transfer of EL patient IgGs or active immunization with group A streptococcus homogenate, human basal ganglia and recombinant proteins (autoantigens)."}